Edition:
United Kingdom

Foamix Pharmaceuticals Ltd (FOMX.OQ)

FOMX.OQ on NASDAQ Stock Exchange Global Market

6.20USD
8:59pm GMT
Change (% chg)

$0.26 (+4.38%)
Prev Close
$5.94
Open
$5.99
Day's High
$6.20
Day's Low
$5.90
Volume
90,708
Avg. Vol
24,214
52-wk High
$11.26
52-wk Low
$4.03

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.25 December 15 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 0 0 0
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.80 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2 1.01 1.12 0.90 --
Quarter Ending Mar-18 3 1.10 1.30 0.90 --
Year Ending Dec-17 4 5.23 10.00 3.50 10.01
Year Ending Dec-18 5 6.87 15.00 3.90 23.67
Earnings (per share)
Quarter Ending Dec-17 1 -0.25 -0.25 -0.25 -0.43
Quarter Ending Mar-18 2 -0.35 -0.24 -0.47 --
Year Ending Dec-17 4 -1.51 -0.95 -1.77 -1.48
Year Ending Dec-18 5 -1.45 -1.04 -1.89 -2.14

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.90 0.90 0.00 0.11
Quarter Ending Jun-17 1.50 0.80 0.70 46.80
Quarter Ending Mar-17 1.50 0.93 0.57 38.20
Quarter Ending Dec-16 0.78 1.49 0.71 90.64
Quarter Ending Sep-16 1.30 2.54 1.24 95.69

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1.01 1.01 1.09 1.09 --
Quarter Ending Mar-18 1.10 1.10 1.30 1.30 --
Year Ending Dec-17 5.23 5.23 5.30 5.30 10.01
Year Ending Dec-18 6.87 6.87 7.65 7.65 23.67

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 1
Earnings